Master pathways and targets in T cell acute lymphoblastic leukaemia

Prof Jean Soulier talks to ecancer at the European School of Haematology (ESH) meeting: International Conference on Acute Lymphoblastic Leukaemia about the various signalling pathways and targets in T-cell acute lymphoblastic leukaemia (ALL).

He describes the implications of the chromosome 6q deletion in this disease along with the possible therapeutic opportunities for this translocation.

As the chair of this session, Prof Soulier also outlines the other signalling pathways that were mentioned in the session, which include NOTCH1, IL7R/PTEN and JAK/STAT.

Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.